Who Exports Cabozantinib from India — 66 Suppliers Behind a $127.4K Market
India's cabozantinib export market is supplied by 66 active exporters who collectively shipped $127.4K across 302 shipments. ROYAL MEDICAL PRIVATE LIMITED leads with a 9.4% market share, followed by HEALTHBIOTICS PRIVATE LIMITED and GALAXY SUPER SPECIALITY. The top 5 suppliers together control 34.0% of total export value, reflecting a moderately competitive market structure.
Top Cabozantinib Exporters from India — Ranked by Export Value
ROYAL MEDICAL PRIVATE LIMITED is the leading cabozantinib exporter from India, holding a 9.4% share of the $127.4K market across 302 shipments from 66 exporters. The top 5 suppliers — ROYAL MEDICAL PRIVATE LIMITED, HEALTHBIOTICS PRIVATE LIMITED, GALAXY SUPER SPECIALITY, RMPL PHARMA LLP, RIZLIFE HEALTHCARE — collectively control 34.0% of total export value, indicating a competitive market. Individual shares are: ROYAL MEDICAL PRIVATE LIMITED (9.4%), HEALTHBIOTICS PRIVATE LIMITED (7.7%), GALAXY SUPER SPECIALITY (6.7%), RMPL PHARMA LLP (5.1%), RIZLIFE HEALTHCARE (5.1%).
Top Cabozantinib Exporters from India
Ranked by export value · 66 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ROYAL MEDICAL PRIVATE LIMITED CAZANAT 60MG TABCABOZANIB 40 MG (3CABOZANIB 60 MG | $12.0K | 1 | 9.4% |
| 2 | HEALTHBIOTICS PRIVATE LIMITED | $9.8K | 1 | 7.7% |
| 3 | GALAXY SUPER SPECIALITY CABOZER 40MG CABOZANTINIB TABLETS 40MGCABOZER 60MG CABOZANTINIB TABLETS 60MGCOBOZANIB 60MG CABOZANTINIB TABLETS 60MG | $8.5K | 2 | 6.7% |
| 4 | RMPL PHARMA LLP CAZANAT 60MG TABCABOZANIB 40 MG (3CABOZANIB 60 MG | $6.5K | 4 | 5.1% |
| 5 | RIZLIFE HEALTHCARE CABOLONG 60MG TABLETS - CABOZANTINIB 60MGCAZANAT 60MG | $6.5K | 1 | 5.1% |
| 6 | ATLAS ENTERPRISES CAZANAT 40MG TAB CABOZANTINIBCAZANAT 60MG TAB CABOZANTINIBCAZANAT 40MG TAB/CABOZANTINIB | $6.1K | 2 | 4.8% |
| 7 | MEDINEX HEALTHCARE CAZANAT 40MG TAB CABOZANTINIBCAZANAT 40MG TAB/CABOZANTINIBCAZANAT 60MG TAB CABOZANTINIB | $4.5K | 1 | 3.5% |
| 8 | RAVI PHARMA CABOZER 60 TABCABOZANTINIB TAB 60MGCABOZER 40 TABCABOZANTINIB TAB. 40MG ASPER INVOICE | $3.8K | 1 | 3.0% |
| 9 | PROSPERA LIFE SCIENCES PRIVATE LIMITED | $3.6K | 3 | 2.8% |
| 10 | KOIT BIOPHARMA PRIVATE LIMITED CAZANAT 40MG TAB / CABOZANTINIBCAZANAT 60MG TAB CABOZANTINIBCAZANAT 60MG TAB CABOZANTINIB NATCO PHANOS | $3.3K | 1 | 2.6% |
| 11 | HEET HEALTHCARE PRIVATE LIMITED | $2.4K | 2 | 1.9% |
| 12 | TRIKAYA GLOBAL CAZANAT 60MG TABCABOZANIB 40 MG (3CABOZANIB 60 MG | $2.4K | 2 | 1.9% |
| 13 | SPECIALITY MEDICINES LIMITED CABOZER 40MG CABOZANTINIB TABLETS 40MGCABOZER 60MG CABOZANTINIB TABLETS 60MGHUMAN HARMLES MEDICINE FOR HUMAN CONSUMPTION- CABOZAT 40MG | $2.2K | 2 | 1.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Cabozantinib exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| SPECIALITY MEDICINES PVT. LTD. | Not Listed | Yes (Certified as of | No | Not verified | Certified for manufacturing tablets, capsules, and external preparations. |
TransData Nexus reviewed the regulatory standing of 1 leading Cabozantinib exporters from India. 0 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Cabozantinib sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for pharmaceutical manufacturing, particularly in active pharmaceutical ingredients (APIs). The city's infrastructure supports large-scale production, making it a strategic location for sourcing Cabozantinib APIs. Notably, Manus Aktteva Biopharma LLP, an ISO 9001:2015 certified global supplier, offers Cabozantinib sourced from manufacturers with supportive regulatory documentation.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. This region hosts numerous companies specializing in the development and production of finished dosage forms. For instance, Aark Pharmaceuticals, based in New Delhi, supplies Cabozantinib formulations like Cabzored, manufactured by Dr. Reddy's Laboratories (Argus).
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products. Its proximity to major ports facilitates efficient international distribution. Companies in this region, such as BDR Pharmaceuticals International Ltd., manufacture Cabozantinib products like Cazanat 40mg, ensuring compliance with global standards.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh is Asia's largest pharmaceutical hub, housing over 3,120 factories with an annual turnover of Rs 60,000 crore. The region offers tax incentives, attracting numerous pharmaceutical companies. Notably, Baddi contributes significantly to the state's industrial revenue and employs a substantial portion of its workforce.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Assess Regulatory Compliance: Ensure suppliers provide comprehensive regulatory documentation, including Drug Master Files (DMFs) and Good Manufacturing Practice (GMP) certifications.
- Evaluate Export Capabilities: Prioritize suppliers with established export experience to key markets such as Turkey, the UAE, Laos, the United States, and Egypt.
- Leverage Tax Incentives: Consider sourcing from regions like Baddi-Nalagarh to benefit from tax incentives, potentially reducing procurement costs.
By strategically sourcing from these diverse pharmaceutical clusters, companies can optimize their supply chain for Cabozantinib, ensuring quality, compliance, and cost-effectiveness.
Common Questions — Cabozantinib Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which cabozantinib supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ROYAL MEDICAL PRIVATE LIMITED leads with 13 recorded shipments worth $12.0K. HEALTHBIOTICS PRIVATE LIMITED (4 shipments) and GALAXY SUPER SPECIALITY (10 shipments) are also established high-volume exporters.
Q How many cabozantinib manufacturers are there in India?
India has 66 active cabozantinib exporters with a combined export market of $127.4K across 302 shipments to 40 countries. The top 5 suppliers hold 34.0% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for cabozantinib from India?
Average FOB unit price: $57.06 per unit, ranging from $0.07 to $1034.00. Average shipment value: $422.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 66 verified Indian exporters of Cabozantinib ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 302 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 40 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
302 Verified Shipments
66 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists